Cavidi

Cavidi Exazym immunoassay signal booster technology improves the sensitivity of immunoassays. Cavidi is the developer of Exazym®, based on the proprietary Binding Oligo Ladder Detection (BOLD) method. This innovation is especially valuable in applications where biomarkers are present at low concentrations, such as in neurological and cardiac research. Cavidi’s ambition is to establish Exazym® as the preferred ultra-sensitive ELISA amplification technique by 2030.

Cavidi Product Portfolio

Cavidi offers a range of Exazym® reagents that can be integrated into both new and existing immunoassays. The workflow is built around three steps, each supported by dedicated kits:

• Conjugation – using the Exazym® ClickChem Conjugation Kit to link an oligo-dT primer to a detector antibody, or the ready-to-use Exazym® Antibody Pairs Kit.
• Signal amplification – a polymerase reaction that significantly boosts the assay signal.
• Detection – Exazym® Detection Kits provide all necessary reagents for platforms such as Gyrolab, SMCxPRO, and Luminex.

This workflow allows researchers to enhance existing assays or develop new ones using Cavidi’s immunoassay signal booster technology.

Expertise and Collaboration

In addition to their product portfolio, Cavidi collaborates with researchers in low-abundance biomarker discovery and immunoassay development. Their expertise supports scientists in advancing detection technologies where sensitivity is critical.

Cavidi at Sanbio

Sanbio partners with Cavidi to make the Exazym® immunoassay signal booster accessible to researchers. With Cavidi’s solutions, scientists can overcome detection limits and improve assay performance in demanding research fields.